Heather Bresch, CEO of Mylan, in an interview with IDA Ireland (Screenshot)
Schools across the country keep EpiPens in their nurses' offices in case a student has a severe allergic reaction. For years, Mylan Pharmaceuticals has been selling the devices to schools at a discounted price, giving them a break from rising costs. But the program also prohibited schools from buying competitors' devices - a provision that experts…
